Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Marantz Jing L. | Director | 10 | $0 | $0 | 2026-06-05 |
| Markels John | Director | 9 | $0 | $0 | 2026-06-05 |
| Slaoui Moncef | Director | 4 | $0 | $0 | 2026-06-05 |
| Marquet Magda | Director | 13 | $64.3K | $0 | 2026-06-05 |
| HOLMES EDWARD W | Director | 12 | $0 | $0 | 2026-06-05 |
| BARLOW JAMES F | Director | 11 | $0 | $0 | 2026-06-05 |
| FARRELL PETER C | Director | 13 | $99.7K | $0 | 2026-06-05 |
| MULROY DENNIS | Chief Financial Officer | 1 | $0 | $0 | 2026-05-01 |
| Roberts Joseph | Controller | 1 | $0 | $0 | 2025-12-17 |
| Kurata Lance | Chief Legal Officer | 7 | $0 | $0 | 2025-12-17 |
| Chivukula Pad | Chief Scientific Officer & COO | 41 | $0 | $12.16M | 2025-12-17 |
| Payne Joseph E | President and CEO | 11 | $170.3K | $0 | 2025-12-17 |
| SASSINE ANDY | Chief Financial Officer | 15 | $453.7K | $1.60M | 2025-08-15 |
| Kummerfeld Keith C | Vice President of Finance | 22 | $20.3K | $440.2K | 2023-12-15 |
| Ultragenyx Pharmaceutical Inc. | Director, 10% Owner | 6 | $0 | $124.28M | 2021-08-11 |
| Parschauer Karah Herdman | Director | 4 | $0 | $0 | 2021-06-18 |
| Hughes Steven George | Chief Development Officer | 2 | $0 | $0 | 2020-12-18 |
| Jones Brian D | CFO and Treasurer | 3 | $11.0K | $0 | 2013-01-22 |
| Manning Susan E | See Remarks | 1 | $0 | $0 | 2013-01-22 |
| Burns Robert | Director | 12 | $0 | $0 | 2013-01-22 |
| Stanley William G | Director | 11 | $0 | $0 | 2013-01-22 |
| Luxor Capital Group, LP | 10% Owner | 5 | $0 | $0 | 2013-01-22 |
| SCHORSCH NICHOLAS S | Director | 3 | $111.0K | $0 | 2013-01-22 |
| MICHELSON LESLIE D | Director | 11 | $0 | $0 | 2013-01-22 |
| KAHANE WILLIAM M | President and CEO | 4 | $111.0K | $0 | 2013-01-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Marantz Jing L. | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Slaoui Moncef | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Markels John | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2026-06-05 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MULROY DENNIS | Chief Financial Officer | A Award deriv | 2026-05-01 | 2026-05-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2025-12-17 | 2025-12-19 | 54,000 | — | $0 | 54,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2025-12-17 | 2025-12-19 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2025-12-17 | 2025-12-19 | 54,000 | — | $0 | 54,000 | SEC↗ |
| Roberts Joseph | Controller | A Award deriv | 2025-12-17 | 2025-12-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2025-08-15 | 2025-08-19 | 1,238 | $16.56 | $20.5K | 221,764 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2025-08-15 | 2025-08-20 | 1,238 | $16.56 | $20.5K | 221,764 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Markels John | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Slaoui Moncef | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2024-12-16 | 2024-12-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2024-12-16 | 2024-12-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2024-12-16 | 2024-12-18 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2024-12-16 | 2024-12-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2024-10-15 | 2024-10-16 | 12,000 | $20.76 | $249.1K | 435,334 | SEC↗ |
| Slaoui Moncef | Director | A Award deriv | 2024-06-19 | 2024-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Slaoui Moncef | Director | A Award deriv | 2024-06-19 | 2024-06-21 | 14,794 | — | $0 | 14,794 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FARRELL PETER C | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| BARLOW JAMES F | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| Markels John | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Markels John | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLMES EDWARD W | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2024-06-14 | 2024-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marantz Jing L. | Director | M Exercise deriv | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 0 | SEC↗ |
| FARRELL PETER C | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 55,741 | SEC↗ |
| BARLOW JAMES F | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 13,131 | SEC↗ |
| Marquet Magda | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 3,131 | SEC↗ |
| Markels John | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 3,131 | SEC↗ |
| HOLMES EDWARD W | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 3,131 | SEC↗ |
| Marantz Jing L. | Director | M Exercise | 2024-06-14 | 2024-06-18 | 3,131 | — | $0 | 3,131 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | S Sale | 2024-06-12 | 2024-06-14 | 50,000 | $32.03 | $1.60M | 220,526 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2024-06-05 | 2024-06-07 | 114 | $45.00 | $5.1K | 447,334 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2024-06-03 | 2024-06-04 | 26,000 | $40.01 | $1.04M | 447,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2024-03-25 | 2024-03-27 | 17,435 | $35.02 | $610.6K | 473,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2024-03-19 | 2024-03-21 | 8,565 | $35.01 | $299.9K | 490,883 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2023-12-15 | 2023-12-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | A Award deriv | 2023-12-15 | 2023-12-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2023-12-15 | 2023-12-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2023-12-15 | 2023-12-19 | 125,000 | — | $0 | 125,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2023-12-15 | 2023-12-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-11-01 | 2023-11-03 | 5,000 | $18.72 | $93.6K | 499,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-10-02 | 2023-10-04 | 5,000 | $25.61 | $128.1K | 504,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-09-01 | 2023-09-05 | 5,000 | $31.45 | $157.3K | 509,448 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award | 2023-08-15 | 2023-08-17 | 1,223 | $17.37 | $21.2K | 270,526 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| Markels John | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 3,131 | — | $0 | 3,131 | SEC↗ |
| Markels John | Director | A Award deriv | 2023-08-01 | 2023-08-03 | 11,869 | — | $0 | 11,869 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-08-01 | 2023-08-03 | 5,000 | $34.91 | $174.5K | 514,448 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-07-14 | 2023-07-18 | 4,500 | — | $0 | 21,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-07-14 | 2023-07-18 | 1,437 | — | $0 | 7,126 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-07-14 | 2023-07-18 | 1,031 | — | $0 | 7,938 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-07-14 | 2023-07-18 | 1,437 | $4.99 | $7.2K | 6,887 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-07-14 | 2023-07-18 | 4,500 | $9.04 | $40.7K | 5,450 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-07-14 | 2023-07-18 | 1,031 | $14.12 | $14.6K | 7,918 | SEC↗ |
| Kummerfeld Keith C | See Remarks | S Sale | 2023-07-14 | 2023-07-18 | 6,968 | $35.00 | $243.9K | 950 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-07-14 | 2023-07-18 | 25,000 | $35.01 | $875.3K | 519,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-07-03 | 2023-07-07 | 5,000 | $28.75 | $143.8K | 544,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-06-01 | 2023-06-05 | 5,000 | $27.16 | $135.8K | 549,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-05-11 | 2023-05-12 | 7,925 | $30.24 | $239.7K | 554,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-05-10 | 2023-05-12 | 17,075 | $30.00 | $512.3K | 562,373 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-05-01 | 2023-05-03 | 5,000 | $25.93 | $129.7K | 579,448 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-04-18 | 2023-04-19 | 1,031 | $14.12 | $14.6K | 1,981 | SEC↗ |
| Kummerfeld Keith C | See Remarks | S Sale | 2023-04-18 | 2023-04-19 | 6,968 | $28.18 | $196.4K | 950 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-04-18 | 2023-04-19 | 1,437 | $4.99 | $7.2K | 7,918 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise | 2023-04-18 | 2023-04-19 | 4,500 | $9.04 | $40.7K | 6,481 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-04-17 | 2023-04-19 | 1,031 | — | $0 | 8,969 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-04-17 | 2023-04-19 | 1,437 | — | $0 | 8,563 | SEC↗ |
| Kummerfeld Keith C | See Remarks | M Exercise deriv | 2023-04-17 | 2023-04-19 | 4,500 | — | $0 | 25,500 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-04-03 | 2023-04-05 | 5,000 | $25.38 | $126.9K | 584,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2023-03-06 | 2023-03-08 | 5,000 | $16.07 | $80.3K | 589,448 | SEC↗ |
| Marquet Magda | Director | P Buy | 2022-12-15 | 2022-12-19 | 2,222 | $18.00 | $40.0K | 24,942 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2022-12-09 | 2022-12-13 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2022-12-09 | 2022-12-13 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2022-12-09 | 2022-12-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2022-12-09 | 2022-12-13 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | A Award deriv | 2022-12-09 | 2022-12-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Markels John | Director | A Award deriv | 2022-12-08 | 2022-12-13 | 6,986 | — | $0 | 6,986 | SEC↗ |
| Markels John | Director | A Award deriv | 2022-12-08 | 2022-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Payne Joseph E | President and CEO | P Buy | 2022-11-23 | 2022-11-28 | 5,000 | $16.51 | $82.6K | 1,480,097 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award | 2022-08-15 | 2022-08-17 | 1,068 | $18.42 | $19.7K | 269,303 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2022-06-21 | 2022-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2022-06-21 | 2022-06-23 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2022-06-21 | 2022-06-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2022-06-21 | 2022-06-23 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | A Award deriv | 2022-06-21 | 2022-06-23 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2022-01-04 | 2022-01-06 | 8,100 | $40.00 | $324.0K | 594,448 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-12-16 | 2021-12-20 | 3,633 | $40.00 | $145.3K | 602,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-12-08 | 2021-12-10 | 6,367 | $40.00 | $254.7K | 606,181 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2021-12-07 | 2021-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Marantz Jing L. | Director | A Award deriv | 2021-12-07 | 2021-12-09 | 6,699 | — | $0 | 6,699 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-11-01 | 2021-11-03 | 10,000 | $44.41 | $444.1K | 612,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-10-01 | 2021-10-04 | 10,000 | $44.36 | $443.6K | 622,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-09-01 | 2021-09-02 | 10,000 | $55.86 | $558.6K | 632,548 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director | S Sale | 2021-08-11 | 2021-08-12 | 75,000 | $45.83 | $3.44M | 1,400,000 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director | S Sale | 2021-08-10 | 2021-08-12 | 725,000 | $55.44 | $40.19M | 1,475,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-08-03 | 2021-08-05 | 10,000 | $40.07 | $400.7K | 642,548 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-04-01 | 2021-04-05 | 10,000 | $42.95 | $429.5K | 652,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-03-01 | 2021-03-03 | 10,000 | $54.23 | $542.3K | 662,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-02-01 | 2021-02-03 | 10,000 | $75.31 | $753.1K | 672,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2021-01-04 | 2021-01-05 | 10,000 | $46.40 | $464.0K | 682,548 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2020-12-18 | 2020-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hughes Steven George | Chief Development Officer | A Award deriv | 2020-12-18 | 2020-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2020-12-18 | 2020-12-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2020-12-18 | 2020-12-22 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2020-12-18 | 2020-12-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | A Award deriv | 2020-12-18 | 2020-12-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director, 10% Owner | S Sale | 2020-12-09 | 2020-12-10 | 357,745 | $94.97 | $33.98M | 2,200,000 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director, 10% Owner | S Sale | 2020-12-08 | 2020-12-10 | 442,255 | $105.54 | $46.68M | 2,557,745 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2020-12-01 | 2020-12-03 | 10,000 | $96.19 | $961.9K | 692,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2020-11-02 | 2020-11-03 | 10,000 | $55.28 | $552.8K | 702,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2020-10-01 | 2020-10-02 | 10,000 | $42.83 | $428.3K | 712,548 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | S Sale | 2020-09-03 | 2020-09-04 | 10,000 | $45.16 | $451.6K | 722,548 | SEC↗ |
| Kurata Lance | Chief Legal Officer | A Award deriv | 2020-08-10 | 2020-08-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | P Buy | 2020-06-12 | 2020-06-12 | 450 | $33.33 | $15.0K | 950 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2020-06-10 | 2020-06-10 | 5,000 | $29.74 | $148.7K | 273,245 | SEC↗ |
| Payne Joseph E | President and CEO | P Buy | 2020-06-10 | 2020-06-10 | 1,000 | $31.69 | $31.7K | 1,475,097 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director, 10% Owner | M Exercise deriv | 2020-05-20 | 2020-05-22 | 600,000 | — | $0 | 0 | SEC↗ |
| Ultragenyx Pharmaceutical Inc. | Director, 10% Owner | M Exercise | 2020-05-20 | 2020-05-22 | 600,000 | $16.00 | $9.60M | 3,000,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2020-02-18 | 2020-02-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | A Award deriv | 2020-02-18 | 2020-02-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Hughes Steven George | Chief Development Officer | A Award deriv | 2020-02-18 | 2020-02-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kummerfeld Keith C | See Remarks | A Award deriv | 2020-02-18 | 2020-02-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2020-02-18 | 2020-02-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2019-12-05 | 2019-12-09 | 5,649 | $9.73 | $55.0K | 268,245 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2019-12-03 | 2019-12-05 | 10,000 | $10.00 | $100.0K | 257,596 | SEC↗ |
| FARRELL PETER C | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HOLMES EDWARD W | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Parschauer Karah Herdman | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BARLOW JAMES F | Director | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Marquet Magda | Director | P Buy | 2019-09-13 | 2019-09-17 | 2,300 | $10.58 | $24.3K | 22,720 | SEC↗ |
| Kummerfeld Keith C | See Remarks | P Buy | 2019-09-12 | 2019-09-12 | 500 | $10.69 | $5.3K | 500 | SEC↗ |
| Payne Joseph E | President and CEO | P Buy | 2019-08-29 | 2019-08-30 | 5,000 | $11.22 | $56.1K | 1,474,097 | SEC↗ |
| SASSINE ANDY | Chief Financial Officer | P Buy | 2019-08-23 | 2019-08-26 | 10,000 | $10.90 | $109.0K | 247,596 | SEC↗ |
| FARRELL PETER C | Director | P Buy | 2019-08-20 | 2019-08-21 | 4,432 | $10.85 | $48.1K | 42,955 | SEC↗ |
| FARRELL PETER C | Director | P Buy | 2019-08-19 | 2019-08-21 | 4,681 | $11.02 | $51.6K | 38,523 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2019-02-07 | 2019-02-11 | 1,667 | $4.99 | $8.3K | 1,667 | SEC↗ |
| Chivukula Pad | Chief Scientific Officer & C | A Award deriv | 2019-02-07 | 2019-02-11 | 38,333 | $4.99 | $191.3K | 38,333 | SEC↗ |
| Kummerfeld Keith C | Vice President of Finance | A Award deriv | 2019-02-07 | 2019-02-11 | 10,000 | $4.99 | $49.9K | 10,000 | SEC↗ |
| Payne Joseph E | President and CEO | A Award deriv | 2019-02-07 | 2019-02-11 | 60,000 | $4.99 | $299.4K | 60,000 | SEC↗ |
| Burns Robert | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Burns Robert | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Burns Robert | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| MICHELSON LESLIE D | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| MICHELSON LESLIE D | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| MICHELSON LESLIE D | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Stanley William G | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Stanley William G | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Stanley William G | Director | D To issuer deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 0 | SEC↗ |
| Burns Robert | Director | D To issuer | 2013-01-22 | 2013-01-24 | 96,085 | — | $0 | 0 | SEC↗ |
| SCHORSCH NICHOLAS S | Director | D To issuer | 2013-01-22 | 2013-01-24 | 993,240 | — | $0 | 0 | SEC↗ |
| SCHORSCH NICHOLAS S | Director | D To issuer | 2013-01-22 | 2013-01-24 | 7,540 | — | $0 | 0 | SEC↗ |
| Jones Brian D | CFO and Treasurer | D To issuer | 2013-01-22 | 2013-01-24 | 24,952 | — | $0 | 0 | SEC↗ |
| KAHANE WILLIAM M | President and CEO | D To issuer | 2013-01-22 | 2013-01-24 | 7,540 | — | $0 | 0 | SEC↗ |
| KAHANE WILLIAM M | President and CEO | D To issuer | 2013-01-22 | 2013-01-24 | 261,451 | — | $0 | 0 | SEC↗ |
| Manning Susan E | See Remarks | D To issuer | 2013-01-22 | 2013-01-24 | 5,000 | — | $0 | 0 | SEC↗ |
| MICHELSON LESLIE D | Director | D To issuer | 2013-01-22 | 2013-01-24 | 30,401 | — | $0 | 0 | SEC↗ |
| Stanley William G | Director | D To issuer | 2013-01-22 | 2013-01-24 | 53,907 | — | $0 | 0 | SEC↗ |
| Stanley William G | Director | D To issuer | 2013-01-22 | 2013-01-24 | 44,667 | — | $0 | 0 | SEC↗ |
| Luxor Capital Group, LP | 10% Owner | J Other | 2013-01-22 | 2013-01-24 | 7,703,397 | — | $0 | 0 | SEC↗ |
| Luxor Capital Group, LP | 10% Owner | J Other | 2013-01-22 | 2013-01-24 | 666,490 | — | $0 | 0 | SEC↗ |
| Luxor Capital Group, LP | 10% Owner | J Other | 2013-01-22 | 2013-01-24 | 753,458 | — | $0 | 0 | SEC↗ |
| Luxor Capital Group, LP | 10% Owner | J Other | 2013-01-22 | 2013-01-24 | 1,820,004 | — | $0 | 0 | SEC↗ |
| Luxor Capital Group, LP | 10% Owner | J Other | 2013-01-22 | 2013-01-24 | 5,626,408 | — | $0 | 0 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award | 2012-06-18 | 2012-07-31 | 2,584 | — | $0 | 25,630 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award | 2012-06-18 | 2012-07-31 | 4,771 | — | $0 | 30,401 | SEC↗ |
| Jones Brian D | CFO and Treasurer | A Award | 2012-06-18 | 2012-06-20 | 13,502 | — | $0 | 24,952 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award | 2012-06-18 | 2012-06-20 | 4,771 | — | $0 | 30,401 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award | 2012-06-18 | 2012-06-20 | 2,584 | — | $0 | 25,630 | SEC↗ |
| Stanley William G | Director | A Award | 2012-06-18 | 2012-06-20 | 4,771 | — | $0 | 44,667 | SEC↗ |
| Stanley William G | Director | A Award | 2012-06-18 | 2012-06-20 | 2,584 | — | $0 | 39,896 | SEC↗ |
| Burns Robert | Director | A Award | 2012-06-18 | 2012-06-20 | 2,584 | — | $0 | 91,314 | SEC↗ |
| Burns Robert | Director | A Award | 2012-06-18 | 2012-06-20 | 4,771 | — | $0 | 96,085 | SEC↗ |
| Jones Brian D | CFO and Treasurer | P Buy | 2012-04-18 | 2012-04-18 | 1,000 | $11.00 | $11.0K | 11,450 | SEC↗ |
| SCHORSCH NICHOLAS S | Director | P Buy | 2012-04-17 | 2012-04-17 | 10,000 | $11.10 | $111.0K | 993,240 | SEC↗ |
| KAHANE WILLIAM M | President and CEO | P Buy | 2012-04-17 | 2012-04-17 | 10,000 | $11.10 | $111.0K | 261,451 | SEC↗ |
| KAHANE WILLIAM M | President and CEO | G Gift | 2012-01-09 | 2012-03-01 | 5,000 | — | $0 | 251,451 | SEC↗ |
| Burns Robert | Director | A Award | 2011-10-01 | 2012-03-01 | 9,818 | $9.00 | $88.4K | 66,895 | SEC↗ |
| Stanley William G | Director | A Award | 2011-10-01 | 2012-03-01 | 13,818 | $9.00 | $124.4K | 26,451 | SEC↗ |
| Burns Robert | Director | A Award | 2011-05-24 | 2012-03-01 | 3,000 | — | $0 | 57,077 | SEC↗ |
| Stanley William G | Director | A Award | 2011-05-24 | 2012-03-01 | 3,000 | — | $0 | 12,633 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award | 2011-05-24 | 2012-03-01 | 3,000 | — | $0 | 12,550 | SEC↗ |
| Burns Robert | Director | A Award deriv | 2010-05-17 | 2012-03-01 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Burns Robert | Director | A Award | 2010-05-17 | 2012-03-01 | 3,000 | — | $0 | 54,077 | SEC↗ |
| Burns Robert | Director | A Award deriv | 2009-05-22 | 2012-03-01 | 3,000 | — | $0 | 6,000 | SEC↗ |
| Stanley William G | Director | A Award deriv | 2009-05-22 | 2012-03-01 | 3,000 | — | $0 | 6,000 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award deriv | 2009-05-22 | 2012-03-01 | 3,000 | — | $0 | 6,000 | SEC↗ |
| Burns Robert | Director | A Award deriv | 2008-01-22 | 2012-03-01 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Stanley William G | Director | A Award deriv | 2008-01-22 | 2012-03-01 | 3,000 | — | $0 | 3,000 | SEC↗ |
| MICHELSON LESLIE D | Director | A Award deriv | 2008-01-22 | 2012-03-01 | 3,000 | — | $0 | 3,000 | SEC↗ |